Transaction #7884 · Form 4 · 0001380632-25-000004
MARAVAI LIFESCIENCES HOLDINGS, INC. · Purchase · Class A Common Stock
MARAVAI LIFESCIENCES HOLDINGS, INC. · Transacted November 11, 2025 · Filed November 13, 2025
What does this filing report?
An SEC Form 4 filing for MARAVAI LIFESCIENCES HOLDINGS, INC. records a purchase involving Class A Common Stock on November 11, 2025. The reported quantity was 157,201. The filing date is November 13, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001823239
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 157,201
- Reported price
- 3.24 · See footnotes
- Reference value
- 509,331.24
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 157,201
- Ownership description
- The Bernd Brust Management Trust
- SEC acceptance time
- Nov 13, 2025, 5:27 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Brust Bernd ↗
Chief Executive Officer · Director
CIK 0001380632
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.18 to $3.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- F2
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.175 to $3.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.